Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
DE0007165607
Tue, 02.07.2024
SARTORIUS AG
Göttingen, July 2, 2024
Sartorius AG: After more than 20 years as CEO, Joachim Kreuzburg will not pursue another term in office – Supervisory Board expresses great regret
The long-standing CEO of Sartorius AG, Dr. Joachim Kreuzburg, has informed the company's Supervisory Board that after more than 20 years as CEO of the company, he will not be s [ … ]
Tue, 02.07.2024
SARTORIUS AG
Disclosure of inside information according to Article 17 MAR
Sartorius AG: After more than 20 years as CEO, Joachim Kreuzburg will not pursue another term in office
The long-standing CEO of Sartorius AG, Dr. Joachim Kreuzburg, has informed the company's Supervisory Board that, after more than 20 years as CEO, he will not be seeking another contr [ … ]
Thu, 16.05.2024
SARTORIUS AG
Göttingen, Germany, May 16, 2024
Sartorius to advance drug discovery and manufacturing with AI in collaboration with NVIDIA
Exploring advanced technologies to help bring novel therapies to patients faster
Sartorius to leverage NVIDIA solutions used in live-cell imaging platforms in drug discovery, and predictive design of manufacturing processe [ … ]
Mon, 13.05.2024
SARTORIUS AG
Göttingen, Germany | May 13, 2024
Sartorius collaborates with Sanofi to commercialize end-to-end platform for downstream process intensification
Sartorius selected as preferred partner for development and commercialization of integrated and continuous biomanufacturing (ICB) platform
Modular platform will combine highest flexibility with stand [ … ]
Thu, 18.04.2024
SARTORIUS AG
Göttingen, April 18, 2024
Sartorius: First quarter results in line with expectations; recurring business with significant order growth; demand from China remains weak; outlook for full year confirmed
Inventory reduction at customers further advanced; order intake increases by almost 10 percent in constant currencies
Sales revenue down by 7.6 [ … ]
Thu, 28.03.2024
SARTORIUS AG
Göttingen, March 28, 2024
Resolutions of the Annual General Meeting of Sartorius AG
At today’s virtual Annual General Meeting, the shareholders of Sartorius AG approved the proposals of the Executive Board and the Supervisory Board by a large majority, including the proposal to distribute a dividend of 0.74 euros per preference share and 0.73 euro [ … ]
Fri, 16.02.2024
SARTORIUS AG
Göttingen, February 16, 2024
Sartorius releases Annual Report for 2023
The life science group Sartorius has released its Annual Report for 2023 today. The document is available under the following link: https://ir-reports.sartorius.com/en/ag/fy-2023. Financial calendar
March 28, 2024 Annual General Meeting
April 18, 2024 Publication of [ … ]
Fri, 09.02.2024
SARTORIUS AG
Göttingen, February 9, 2024
The Supervisory Board of Sartorius AG proposes
a dividend of 0.74 euros per preference share
The Supervisory Board of Sartorius AG resolved at its meeting today to approve the recommendation of the Executive Board to submit a proposal to the Annual General Meeting on March 28, 2024, to pay a dividend of 0.74 euros per [ … ]
Wed, 07.02.2024
SARTORIUS AG
Disclosure of an inside information according to Article 17 of the Regulation (EU) No 596/2014 (MAR)
Not to be released, published, distributed or circulated in South Africa, Canada, Australia, Japan or any other jurisdiction in which it would be unlawful to do so. This notification is not a prospectus within the meaning of Regulation (EU) 2017/11 [ … ]
Tue, 06.02.2024
SARTORIUS AG
Disclosure of an inside information according to Article 17 of the Regulation (EU) No 596/2014 (MAR)
Not to be released, published, distributed or circulated in South Africa, Canada, Australia, Japan or any other jurisdiction in which it would be unlawful to do so. This notification is not a prospectus within the meaning of Regulation (EU) 2017/11 [ … ]